ACE2 and urogenital neoplasm: Activation of VDR has been shown to inhibit expression of the angiotensin-converting enzyme 2 (ACE2) protein in the renal tubular cells, a receptor to which SARS-CoV-2 virus can bind to, and thus may protect against acute kidney injury caused by direct cytopathic effect of the virus [59,60].